This website was discontinued on 20/12/2022. Visit the new website at

Skip nav

R&D Projects

Confirmed projects database queries

The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.

Call for Funding of Research and Development Projects in all Scientific Domains - 2009

Health Sciences - Biomaterials

    Painel de Avaliação da área das Ciências da Saúde - 2009
  • Fernando Giraldez Orgaz
  • Jean-Michel Bouler
  • Sergio Cerutti
  • Geert van der Heijden
  • Ad Geurts van Kessel
  • Caetano Reis e Sousa
  • George Griffin
  • Roland Pochet
  • Louis Lemieux
  • Stephen Paul Hilary Alexander
  • Peter Illes
  • Humphrey Hodgson
  • Rolf Jackisch
  • Marc Mareel
  • Maxime GUYE
  • Marc Moreau
  • Bruno Bujoli
  • Derek Macallan
  • Andrew Westwell
  • John Martin
  • Gordon Stewart
  • Robert Hofstra
  • Maurice Zeegers
  • Gerard J te Meerman
  • Geert Martens
  • Jean Vanderpas
  • Mark Van de Casteele

Skin2: a biosynthetic second skin, engineered to treat severe burn wounds. Jorge Alexandre Monteiro de Carvalho e Silva, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €160,000.


Nanohydroxyapatite antibacterial surfaces to prevent biofilm associated bone infection (NaNOBiofilm). MARIA PIA DE MELO ALVIM FERRAZ TAVARES, Instituto Nacional de Engenharia Biomédica - INEB Univ. Porto (INEB Porto). €150,000.


GIANTCELL - The modulation of macrophages to resolve inflammatory reactions to biomaterials through the induction of the M2 phenotype. Maria Judite Tavares Moreira Novais Barbosa, Instituto Nacional de Engenharia Biomédica - INEB Univ. Porto (INEB Porto). €115,000.


Intracellular Drug Delivery Systems and Tissue Engineering as a Combinatory Approach for Spinal Cord Injury Regeneration. António José Braga Osório Gomes Salgado, Universidade do Minho (UM). €165,000.


Development of a novel therapeutic strategy for pancreatic cancer involving a concerted action of gene therapy and chemotherapeutic agents. Henrique Manuel Santos Faneca, Centro de Neurociências e Biologia Celular (CNBC/UC). €100,000.